Azenta, Inc. (NASDAQ: AZTA) Stock Competitors & Peer Comparison
See AZTA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AZTA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AZTA | $45.29 | +11.88% | 2.1B | 116.43 | $0.42 | N/A |
| ISRG | $442.71 | -1.63% | 155.8B | 46.73 | $9.62 | N/A |
| BDX | $215.47 | +1.35% | 58.4B | 16.50 | $13.00 | +1.86% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.86% |
| MDLN | $41.20 | +0.71% | 37B | 30.89 | $1.36 | N/A |
| RMD | $242.23 | +3.76% | 33.6B | 20.69 | $11.53 | +1.06% |
| WST | $413.09 | +0.13% | 28.8B | 44.88 | $9.20 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $89.30 | -0.87% | 15.1B | 12.48 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.86% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
AZTA vs ISRG Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ISRG has a market cap of 155.8B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ISRG trades at $442.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ISRG's P/E ratio is 46.73. In terms of profitability, AZTA's ROE is -0.11%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, AZTA is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDX)
AZTA vs BDX Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BDX has a market cap of 58.4B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BDX trades at $215.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BDX's P/E ratio is 16.50. In terms of profitability, AZTA's ROE is -0.11%, compared to BDX's ROE of +0.04%. Regarding short-term risk, AZTA is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
AZTA vs BDXA Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BDXA's P/E ratio is 45.70. In terms of profitability, AZTA's ROE is -0.11%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, AZTA is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
AZTA vs MDLN Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, MDLN has a market cap of 37B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while MDLN trades at $41.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas MDLN's P/E ratio is 30.89. In terms of profitability, AZTA's ROE is -0.11%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, AZTA is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check MDLN's competition here
ResMed Inc. (NYSE: RMD)
AZTA vs RMD Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, RMD has a market cap of 33.6B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while RMD trades at $242.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas RMD's P/E ratio is 20.69. In terms of profitability, AZTA's ROE is -0.11%, compared to RMD's ROE of +0.25%. Regarding short-term risk, AZTA is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check RMD's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
AZTA vs WST Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, WST has a market cap of 28.8B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while WST trades at $413.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas WST's P/E ratio is 44.88. In terms of profitability, AZTA's ROE is -0.11%, compared to WST's ROE of +0.21%. Regarding short-term risk, AZTA is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
AZTA vs HOLX Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas HOLX's P/E ratio is 31.54. In terms of profitability, AZTA's ROE is -0.11%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, AZTA is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
AZTA vs SOLV Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, SOLV has a market cap of 15.1B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while SOLV trades at $89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas SOLV's P/E ratio is 12.48. In terms of profitability, AZTA's ROE is -0.11%, compared to SOLV's ROE of +0.03%. Regarding short-term risk, AZTA is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
AZTA vs BDXB Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BDXB's P/E ratio is 7.60. In terms of profitability, AZTA's ROE is -0.11%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, AZTA is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
AZTA vs BAX Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BAX has a market cap of 13.6B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BAX trades at $26.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BAX's P/E ratio is 12.66. In terms of profitability, AZTA's ROE is -0.11%, compared to BAX's ROE of -0.12%. Regarding short-term risk, AZTA is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
AZTA vs COO Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, COO has a market cap of 12B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while COO trades at $62.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas COO's P/E ratio is 13.80. In terms of profitability, AZTA's ROE is -0.11%, compared to COO's ROE of +0.07%. Regarding short-term risk, AZTA is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
AZTA vs RGEN Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, RGEN has a market cap of 11B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while RGEN trades at $167.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas RGEN's P/E ratio is 95.86. In terms of profitability, AZTA's ROE is -0.11%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, AZTA is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
AZTA vs AVTR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, AVTR has a market cap of 10.7B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while AVTR trades at $15.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas AVTR's P/E ratio is 18.50. In terms of profitability, AZTA's ROE is -0.11%, compared to AVTR's ROE of +0.06%. Regarding short-term risk, AZTA is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
AZTA vs ATR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ATR has a market cap of 9.1B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ATR trades at $141.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ATR's P/E ratio is 25.01. In terms of profitability, AZTA's ROE is -0.11%, compared to ATR's ROE of +0.10%. Regarding short-term risk, AZTA is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
AZTA vs BLCO Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BLCO has a market cap of 7.6B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BLCO trades at $21.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BLCO's P/E ratio is 32.78. In terms of profitability, AZTA's ROE is -0.11%, compared to BLCO's ROE of -0.02%. Regarding short-term risk, AZTA is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
AZTA vs TFX Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, TFX has a market cap of 6.2B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while TFX trades at $154.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas TFX's P/E ratio is 17.87. In terms of profitability, AZTA's ROE is -0.11%, compared to TFX's ROE of +0.10%. Regarding short-term risk, AZTA is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
AZTA vs MMSI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, MMSI has a market cap of 5.3B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while MMSI trades at $87.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas MMSI's P/E ratio is 22.52. In terms of profitability, AZTA's ROE is -0.11%, compared to MMSI's ROE of +0.10%. Regarding short-term risk, AZTA is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
AZTA vs ICUI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ICUI has a market cap of 4.5B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ICUI trades at $178.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ICUI's P/E ratio is 22.25. In terms of profitability, AZTA's ROE is -0.11%, compared to ICUI's ROE of +0.03%. Regarding short-term risk, AZTA is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
AZTA vs PLSE Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, PLSE has a market cap of 4.2B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while PLSE trades at $56.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas PLSE's P/E ratio is -48.29. In terms of profitability, AZTA's ROE is -0.11%, compared to PLSE's ROE of -0.78%. Regarding short-term risk, AZTA is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
AZTA vs NVST Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NVST has a market cap of 4.1B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NVST trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NVST's P/E ratio is 17.21. In terms of profitability, AZTA's ROE is -0.11%, compared to NVST's ROE of +0.21%. Regarding short-term risk, AZTA is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check NVST's competition here
Stevanato Group S.p.A. (NYSE: STVN)
AZTA vs STVN Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, STVN has a market cap of 3.8B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while STVN trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas STVN's P/E ratio is 20.95. In terms of profitability, AZTA's ROE is -0.11%, compared to STVN's ROE of +0.09%. Regarding short-term risk, AZTA is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check STVN's competition here
AtriCure, Inc. (NASDAQ: ATRC)
AZTA vs ATRC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ATRC trades at $57.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ATRC's P/E ratio is 1786.65. In terms of profitability, AZTA's ROE is -0.11%, compared to ATRC's ROE of +0.03%. Regarding short-term risk, AZTA is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
AZTA vs XRAY Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while XRAY trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas XRAY's P/E ratio is 6.83. In terms of profitability, AZTA's ROE is -0.11%, compared to XRAY's ROE of -0.09%. Regarding short-term risk, AZTA is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check XRAY's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
AZTA vs BLFS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BLFS's P/E ratio is 37.49. In terms of profitability, AZTA's ROE is -0.11%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, AZTA is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
AZTA vs KMTS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, KMTS has a market cap of 1.9B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while KMTS trades at $29.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas KMTS's P/E ratio is -11.94. In terms of profitability, AZTA's ROE is -0.11%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, AZTA is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check KMTS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
AZTA vs LMAT Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while LMAT trades at $78.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas LMAT's P/E ratio is 29.15. In terms of profitability, AZTA's ROE is -0.11%, compared to LMAT's ROE of +0.15%. Regarding short-term risk, AZTA is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check LMAT's competition here
STAAR Surgical Company (NASDAQ: STAA)
AZTA vs STAA Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while STAA trades at $27.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas STAA's P/E ratio is 46.82. In terms of profitability, AZTA's ROE is -0.11%, compared to STAA's ROE of +0.00%. Regarding short-term risk, AZTA is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
AZTA vs ATRI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ATRI's P/E ratio is 64.50. In terms of profitability, AZTA's ROE is -0.11%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, AZTA is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
AZTA vs ANGO Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ANGO has a market cap of 522.3M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ANGO trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ANGO's P/E ratio is -31.85. In terms of profitability, AZTA's ROE is -0.11%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, AZTA is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
AZTA vs MMEDV Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas MMEDV's P/E ratio is N/A. In terms of profitability, AZTA's ROE is -0.11%, compared to MMEDV's ROE of N/A. Regarding short-term risk, AZTA is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
AZTA vs EMBC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, EMBC has a market cap of 370M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while EMBC trades at $6.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas EMBC's P/E ratio is 2.51. In terms of profitability, AZTA's ROE is -0.11%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, AZTA is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
AZTA vs SMTI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, SMTI has a market cap of 290.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while SMTI trades at $32.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas SMTI's P/E ratio is -526.83. In terms of profitability, AZTA's ROE is -0.11%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, AZTA is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
AZTA vs OSUR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, OSUR has a market cap of 245.5M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while OSUR trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas OSUR's P/E ratio is -5.16. In terms of profitability, AZTA's ROE is -0.11%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, AZTA is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check OSUR's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
AZTA vs PDEX Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, PDEX has a market cap of 228.8M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while PDEX trades at $69.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas PDEX's P/E ratio is 19.59. In terms of profitability, AZTA's ROE is -0.11%, compared to PDEX's ROE of +0.26%. Regarding short-term risk, AZTA is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check PDEX's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
AZTA vs UTMD Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, UTMD has a market cap of 208.1M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while UTMD trades at $73.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas UTMD's P/E ratio is 21.61. In terms of profitability, AZTA's ROE is -0.11%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, AZTA is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check UTMD's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
AZTA vs KRMD Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, KRMD has a market cap of 178.7M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while KRMD trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas KRMD's P/E ratio is -97.25. In terms of profitability, AZTA's ROE is -0.11%, compared to KRMD's ROE of -0.00%. Regarding short-term risk, AZTA is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check KRMD's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
AZTA vs NNNN Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NNNN has a market cap of 174.8M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NNNN trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NNNN's P/E ratio is 26.55. In terms of profitability, AZTA's ROE is -0.11%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, AZTA is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check NNNN's competition here
Stereotaxis, Inc. (AMEX: STXS)
AZTA vs STXS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, STXS has a market cap of 90.2M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while STXS trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas STXS's P/E ratio is -5.29. In terms of profitability, AZTA's ROE is -0.11%, compared to STXS's ROE of -1.16%. Regarding short-term risk, AZTA is more volatile compared to STXS. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
AZTA vs AKYA Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas AKYA's P/E ratio is -1.34. In terms of profitability, AZTA's ROE is -0.11%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, AZTA is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check AKYA's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
AZTA vs POCI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, POCI has a market cap of 55.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while POCI trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas POCI's P/E ratio is -10.98. In terms of profitability, AZTA's ROE is -0.11%, compared to POCI's ROE of -0.24%. Regarding short-term risk, AZTA is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check POCI's competition here
SkyAI, Inc. (NASDAQ: STSS)
AZTA vs STSS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas STSS's P/E ratio is -0.02. In terms of profitability, AZTA's ROE is -0.11%, compared to STSS's ROE of -0.99%. Regarding short-term risk, AZTA is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
AZTA vs OMIC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas OMIC's P/E ratio is -0.58. In terms of profitability, AZTA's ROE is -0.11%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, AZTA is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
AZTA vs IGAP Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas IGAP's P/E ratio is -10.52. In terms of profitability, AZTA's ROE is -0.11%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, AZTA is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check IGAP's competition here
Daxor Corporation (NASDAQ: DXR)
AZTA vs DXR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, DXR has a market cap of 49.3M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while DXR trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas DXR's P/E ratio is 6.86. In terms of profitability, AZTA's ROE is -0.11%, compared to DXR's ROE of +0.13%. Regarding short-term risk, AZTA is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check DXR's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
AZTA vs HBIO Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, HBIO has a market cap of 44.1M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while HBIO trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas HBIO's P/E ratio is -26.89. In terms of profitability, AZTA's ROE is -0.11%, compared to HBIO's ROE of -1.30%. Regarding short-term risk, AZTA is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check HBIO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
AZTA vs ZJYL Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ZJYL has a market cap of 38.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ZJYL trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ZJYL's P/E ratio is 33.58. In terms of profitability, AZTA's ROE is -0.11%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, AZTA is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check ZJYL's competition here
Nephros, Inc. (NASDAQ: NEPH)
AZTA vs NEPH Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NEPH has a market cap of 33.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NEPH trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NEPH's P/E ratio is 51.17. In terms of profitability, AZTA's ROE is -0.11%, compared to NEPH's ROE of +0.17%. Regarding short-term risk, AZTA is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
AZTA vs SDC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas SDC's P/E ratio is -0.03. In terms of profitability, AZTA's ROE is -0.11%, compared to SDC's ROE of -1.96%. Regarding short-term risk, AZTA is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
AZTA vs MLSS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, MLSS has a market cap of 27.9M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while MLSS trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas MLSS's P/E ratio is -6.15. In terms of profitability, AZTA's ROE is -0.11%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, AZTA is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
AZTA vs IVC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas IVC's P/E ratio is -0.79. In terms of profitability, AZTA's ROE is -0.11%, compared to IVC's ROE of -0.46%. Regarding short-term risk, AZTA is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
AZTA vs RVP Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, RVP has a market cap of 16.6M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while RVP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas RVP's P/E ratio is -4.62. In terms of profitability, AZTA's ROE is -0.11%, compared to RVP's ROE of -0.05%. Regarding short-term risk, AZTA is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
AZTA vs BNGO Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, BNGO has a market cap of 13M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while BNGO trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas BNGO's P/E ratio is -0.36. In terms of profitability, AZTA's ROE is -0.11%, compared to BNGO's ROE of -0.85%. Regarding short-term risk, AZTA is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
AZTA vs FEMY Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, FEMY has a market cap of 12.6M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while FEMY trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas FEMY's P/E ratio is -0.33. In terms of profitability, AZTA's ROE is -0.11%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, AZTA is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
AZTA vs RGNT Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, RGNT has a market cap of 8.9M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while RGNT trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas RGNT's P/E ratio is -0.52. In terms of profitability, AZTA's ROE is -0.11%, compared to RGNT's ROE of N/A. Regarding short-term risk, AZTA is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
AZTA vs LUCY Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, LUCY has a market cap of 7.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while LUCY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas LUCY's P/E ratio is -0.65. In terms of profitability, AZTA's ROE is -0.11%, compared to LUCY's ROE of -1.03%. Regarding short-term risk, AZTA is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
AZTA vs NSTG Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NSTG's P/E ratio is -0.03. In terms of profitability, AZTA's ROE is -0.11%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, AZTA is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
AZTA vs CUPR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, CUPR has a market cap of 4.6M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while CUPR trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas CUPR's P/E ratio is -1.24. In terms of profitability, AZTA's ROE is -0.11%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, AZTA is more volatile compared to CUPR. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
AZTA vs POAI Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas POAI's P/E ratio is -0.38. In terms of profitability, AZTA's ROE is -0.11%, compared to POAI's ROE of -21.19%. Regarding short-term risk, AZTA is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
AZTA vs MHUA Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas MHUA's P/E ratio is 0.25. In terms of profitability, AZTA's ROE is -0.11%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, AZTA is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
AZTA vs NXGL Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NXGL has a market cap of 2M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NXGL trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NXGL's P/E ratio is -5.84. In terms of profitability, AZTA's ROE is -0.11%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, AZTA is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
AZTA vs GMVD Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas GMVD's P/E ratio is -0.01. In terms of profitability, AZTA's ROE is -0.11%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, AZTA is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
AZTA vs GMVDW Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas GMVDW's P/E ratio is N/A. In terms of profitability, AZTA's ROE is -0.11%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, AZTA is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
AZTA vs AVGR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas AVGR's P/E ratio is -0.05. In terms of profitability, AZTA's ROE is -0.11%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, AZTA is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
AZTA vs NXGLW Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, NXGLW has a market cap of 542.8K. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas NXGLW's P/E ratio is -0.01. In terms of profitability, AZTA's ROE is -0.11%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, AZTA is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
AZTA vs LUCYW Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas LUCYW's P/E ratio is N/A. In terms of profitability, AZTA's ROE is -0.11%, compared to LUCYW's ROE of -1.03%. Regarding short-term risk, AZTA is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for AZTA.Check LUCYW's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
AZTA vs HRC Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, HRC has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas HRC's P/E ratio is 41.92. In terms of profitability, AZTA's ROE is -0.11%, compared to HRC's ROE of +0.14%. Regarding short-term risk, AZTA is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
AZTA vs ALOG Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ALOG's P/E ratio is 40.93. In terms of profitability, AZTA's ROE is -0.11%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, AZTA is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
AZTA vs ATRS Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas ATRS's P/E ratio is 14.95. In terms of profitability, AZTA's ROE is -0.11%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, AZTA is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check ATRS's competition here
IntriCon Corporation (NASDAQ: IIN)
AZTA vs IIN Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, IIN has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas IIN's P/E ratio is 226.45. In terms of profitability, AZTA's ROE is -0.11%, compared to IIN's ROE of -0.00%. Regarding short-term risk, AZTA is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check IIN's competition here
Apria, Inc. (NASDAQ: APR)
AZTA vs APR Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, APR has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas APR's P/E ratio is 22.59. In terms of profitability, AZTA's ROE is -0.11%, compared to APR's ROE of +9.81%. Regarding short-term risk, AZTA is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check APR's competition here
Invuity, Inc. (NASDAQ: IVTY)
AZTA vs IVTY Comparison November 2026
Azenta, Inc. (NASDAQ: AZTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZTA stands at 2.1B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, AZTA is priced at $45.29 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZTA currently has a P/E ratio of 116.43, whereas IVTY's P/E ratio is -3.80. In terms of profitability, AZTA's ROE is -0.11%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, AZTA is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for AZTA.Check IVTY's competition here